rss
J Clin Pathol 2007;60:483-486 doi:10.1136/jcp.2005.033407
  • Original article

Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer

  1. Matthias Woenckhaus1,
  2. Lukas Bubendorf2,
  3. Peter Dalquen2,
  4. Julia Foerster1,
  5. Hagen Blaszyk3,
  6. Martina Mirlacher4,
  7. Markus Soler5,
  8. Wolfgang Dietmaier1,
  9. Guido Sauter4,
  10. Arndt Hartmann1,
  11. Peter J Wild4
  1. 1Institute of Pathology, University of Regensburg, Regensburg, Germany
  2. 2Institute of Pathology, University of Basel, Basel, Switzerland
  3. 3Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA
  4. 4Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  5. 5Pulmonary Division, Department of Internal Medicine, University of Basel, Basel, Switzerland
  1. Correspondence to:
 Dr M Woenckhaus
 Institute of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany; matthias.woenckhaus{at}klinik.uni-r.de
  • Accepted 27 February 2006
  • Published Online First 12 May 2006

Abstract

Aim: To investigate whether nuclear and cytoplasmic Maspin expression is associated with distinct clinicopathological parameters and TP53 expression in a representative series of primary non-small cell lung cancer (NSCLC).

Methods: Tissue microarrays (n = 487) were used to immunohistochemically analyse expression of Maspin and TP53. Cytoplasmic and nuclear expression of Maspin was scored on the basis of the percentage of positive tumour cells. Univariate analysis of clinicopathological variables potentially affecting tumour-specific survival was performed.

Results: Immunohistochemical Maspin expression (nuclear and cytoplasmic) was informative in 72.3% (352/487) of cases. Cytoplasmic and nuclear Maspin immunoreactivity in ≥10% of tumour cells was detected in 37.8% (133/352) and 65.3% (230/352) of informative cases, respectively. Nuclear and cytoplasmic Maspin staining was observed more frequently in primary squamous cell carcinomas than in other lung cancer types. Only nuclear Maspin immunoreactivity was significantly associated with positive TP53 staining. Cytoplasmic or nuclear Maspin expression was not associated with tumour-specific survival.

Conclusion: Maspin expression was found both in the nucleus and the cytoplasm of NSCLC, more frequently in squamous cell carcinomas. However, no association with tumour-specific survival could be demonstrated.

Footnotes

  • Published Online First 12 May 2006

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jcp.2005.033407v1
    2. 60/5/483 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.